[ad_1] Johnson & Johnson will acquire cancer-treatment developer Ambrx Biopharma in a $2 billion cash deal. The pharmaceutical giant said Monday that the deal to acquire all shares of Ambrx…
Tag: Scientific Research Services
Johnson & Johnson to Acquire Cancer-Treatment Developer Amrbx for $2B
[ad_1] Johnson & Johnson will acquire cancer-treatment developer Ambrx Biopharma in a $2 billion cash deal. The pharmaceutical giant said Monday that the deal to acquire all shares of Ambrx…
Gene Editing Will Change Medicine—and Maybe Health Investing Too
[ad_1] It usually takes time for scientific discoveries in the lab to make their way to the market. The groundbreaking gene-editing technology known as Crispr, which acts like a molecular…
New Treatment for Bladder Cancer Offers This Biotech a Second Chance
[ad_1] UroGen hopes to have success with a new treatment after its first drug was a commercial flop. [ad_2] Source link
Pfizer’s Covid Boost Crashes to Earth
[ad_1] This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or…
Pfizer Misses Revenue Expectations, Bets on Drug Launches to Ease Shortfall
[ad_1] The company is rolling out 19 products or new uses within 18 months, CEO Albert Bourla said. [ad_2] Source link
Deadly Fungi Are Becoming More Common And We’re Running Out of Ways to Treat Them
[ad_1] Research suggests fungicides are weakening antifungals before they are up for approval. [ad_2] Source link
Titanic Sub Company Promoted Ties With Aerospace Giants
[ad_1] The OceanGate CEO spoke of relationships with partners such as Boeing, which now calls the claims overstated. [ad_2] Source link